These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3495600

  • 1. Generation of NK cell activity from human bone marrow.
    Lotzová E, Savary CA.
    J Immunol; 1987 Jul 01; 139(1):279-84. PubMed ID: 3495600
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 3. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
    Condiotti R, Nagler A.
    Exp Hematol; 1998 Jul 01; 26(7):571-9. PubMed ID: 9657131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 Jul 01; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK, Doyle LV, Bradley EC.
    J Immunol; 1986 Nov 01; 137(9):2814-22. PubMed ID: 2944965
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human natural killer cell development from bone marrow progenitors: analysis of phenotype, cytotoxicity and growth.
    Lotzová E, Savary CA.
    Nat Immun; 1993 Nov 01; 12(4-5):209-17. PubMed ID: 8257827
    [Abstract] [Full Text] [Related]

  • 11. Induction of NK cell activity against fresh human leukemia in culture with interleukin 2.
    Lotzová E, Savary CA, Herberman RB.
    J Immunol; 1987 Apr 15; 138(8):2718-27. PubMed ID: 3494084
    [Abstract] [Full Text] [Related]

  • 12. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
    Abo T, Cooper MD, Balch CM.
    J Immunol; 1982 Oct 15; 129(4):1752-7. PubMed ID: 6980948
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR, Mason AT, Gerard JP, Henderson LE, Farrar W, Hopkins RF, Herberman RB, Rabin H.
    J Immunol; 1984 Aug 15; 133(2):779-83. PubMed ID: 6203980
    [Abstract] [Full Text] [Related]

  • 15. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
    Migliorati G, Cannarile L, Herberman RB, Bartocci A, Stanley ER, Riccardi C.
    J Immunol; 1987 Jun 01; 138(11):3618-25. PubMed ID: 2884255
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B, Ramoni C, Anegon I, Cuturi MC, Faust J, Trinchieri G.
    Nat Immun Cell Growth Regul; 1987 Jun 01; 6(4):171-88. PubMed ID: 2960890
    [Abstract] [Full Text] [Related]

  • 18. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F, Pardo N, Peiró M, Bertran E, Amill B, García J, Cubells J, Rueda F.
    Exp Hematol; 1995 Dec 01; 23(14):1445-52. PubMed ID: 8542930
    [Abstract] [Full Text] [Related]

  • 19. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
    Lotzová E, Savary CA, Champlin RE.
    J Immunol; 1993 Jun 15; 150(12):5263-9. PubMed ID: 7685792
    [Abstract] [Full Text] [Related]

  • 20. Common precursor pool marker for allospecific (CTL) and nonspecific (NK and activated) cytotoxic cells in the bone marrow.
    Nieminen P, Saksela E.
    J Immunol; 1985 Feb 15; 134(2):699-703. PubMed ID: 3155539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.